Executive Summary

The AI-Powered Medical Imaging Market stood at 2.1 USD Billion in 2025 and is set to reach 19.6 USD Billion by 2035, a CAGR of 25.03% across the forecast period.

Growth is being pulled by radiologist workforce shortages that push triage software into emergency and screening workflows, and by the migration of AI-assisted reads onto reimbursable CPT and HCPCS codes under CMS coverage policy. FDA clearance remains the gating step before hospital procurement, with most triage and detection algorithms routed through the 510(k) or De Novo pathway rather than PMA. The EU AI Act’s high-risk classification of diagnostic imaging algorithms is now layering a second compliance route on top of EU MDR conformity assessment.

North America led with 40.0% of revenue in 2025, followed by Asia Pacific at 29.0% and Europe at 21.0%. Software Tools / Platforms lead the offering axis, and Computed Tomography is the dominant imaging modality across indications.

EU MDR conformity assessment, and in Japan a PMDA review, remain structural costs for hardware-bundled entrants seeking label expansion across geographies. Patient imaging data handled by these platforms also falls under HIPAA in the United States and GDPR in the European Union, adding a data-governance layer to market access. The market stays fragmented, spanning imaging OEMs, standalone software vendors, and hospital-system integrators, with no single supplier holding a dominant position.

Key Takeaways

• The market was valued at USD 2.1 Billion in 2025 and is projected to reach USD 19.6 Billion by 2035, a 25.03% CAGR.
• Software Tools / Platforms lead the offering axis, ahead of Services and Hardware / Integrated Solutions.
• Computed Tomography leads the imaging-modality axis, ahead of MRI, X-ray, ultrasound, and PET/SPECT.
• North America held 40.0% of the market in 2025, ahead of Asia Pacific at 29.0% and Europe at 21.0%.
• Reimbursement coding for AI-assisted reads is converting hospital pilot deployments into standing procurement.
• The EU AI Act’s high-risk classification of imaging algorithms is lengthening conformity-assessment timelines.

Market Definition and Scope

The AI-Powered Medical Imaging Market covers the software, services, and hardware that apply machine learning to radiology, pathology, and diagnostic images across the care pathway. It spans image analysis and diagnostic software, workflow orchestration and triage tools, image reconstruction engines, and PACS/RIS integration, alongside AI-enabled CT, MRI, X-ray, and ultrasound systems, edge AI computing hardware, and the deployment, training, and support services that put these tools into clinical use.

Excluded are general hospital IT and electronic health record systems, non-AI PACS archiving sold without embedded processing capability, and conventional imaging hardware that carries no bundled or add-on AI function.

Growth Drivers and Restraints

Radiologist Shortages Are Shifting Case Reads Toward AI Triage Software

Persistent radiologist shortages are pushing hospitals to insert triage software ahead of the reading queue, flagging emergent findings before a clinician opens the study. This is pulling demand into the Workflow Orchestration & Triage Software category within Software Tools / Platforms, concentrated in emergency departments and population-screening programs. The FDA’s 510(k) and De Novo pathways for AI/ML-enabled software as a medical device give cleared triage algorithms a defined route into US hospital procurement, while the EU MDR’s conformity-assessment route lets the same software carry a CE mark into European emergency care.

CT and MRI Throughput Pressure Is Pulling Reconstruction Software Into Purchasing Cycles

Rising scan volumes are pushing hospitals to pair CT and MRI systems, the leading imaging-modality segment, with AI reconstruction software that cuts noise and scan time to raise machine throughput without added capital equipment. CMS reimbursement codes covering AI-assisted post-processing give radiology departments a billable basis to fund the software rather than absorb it as overhead, while the EU MDR’s clinical-evidence requirement is steering European buyers toward reconstruction tools with completed conformity assessments.

Reimbursement Coding Is Converting Pilot Deployments Into Standing Contracts

Once a procedure code exists for an AI-assisted diagnostic read, hospital finance teams can move the software from a grant-funded pilot to a recurring line item. This is concentrating spend in Image Analysis & Diagnostic Software, particularly for oncology and cardiology studies where a second AI read supports the primary report. National health technology assessment reviews in Europe are performing the same coverage function that CMS coding performs in the US, giving vendors two parallel reimbursement routes to convert trial sites into contracts.

EU AI Act High-Risk Classification Is Lengthening Conformity Timelines

The EU AI Act classifies diagnostic imaging algorithms as high-risk, layering a rigorous conformity assessment on top of existing EU MDR device classification and slowing the cross-border model training vendors rely on to validate software across sites. The combined MDR and AI Act burden extends time-to-market most for smaller software entrants without an existing CE-marked hardware line, reinforcing a structural gap between Europe’s 21.0% share and North America’s 40.0%.

Data-Privacy Rules Are Limiting the Multi-Site Data Developers Need to Validate Models

HIPAA in the US and the GDPR’s health-data provisions in the EU restrict how imaging data moves between hospital systems, slowing the multi-site validation that diagnostic algorithms need before regulatory submission. This falls hardest on smaller software vendors without pre-existing data-sharing agreements across hospital networks, reinforcing a fragmented competitive field built around single-institution pilots rather than portable, cross-site models.

Market Trends

AI Triage Software Is Moving From Radiology Backlogs Into Point-of-Care Screening

Workflow orchestration and triage software, originally deployed to flag urgent findings inside hospital PACS queues, is extending into handheld and point-of-care ultrasound reads. The FDA’s software-as-a-medical-device clearance pathway now covers point-of-care algorithms as well as fixed radiology installations, opening emergency departments and rural clinics to tools once confined to hospital reading rooms. Demand shifts toward the Workflow Orchestration & Triage Software and Handheld/POCUS categories through the forecast period.

Reimbursement Coding Is Turning Pilot Programs Into Standing Procurement

CMS coding decisions for AI-assisted post-processing in the US, paired with national health technology assessment coverage reviews in Europe, are giving hospital finance teams a billable basis to convert single-site pilots into multi-year contracts. This is concentrating spend in Image Analysis & Diagnostic Software, the segment most directly tied to a reimbursable diagnostic output rather than a workflow efficiency gain.

EU MDR and AI Act Rules Are Pushing Vendors to Bundle Certification With Hardware

Because the EU AI Act classifies diagnostic imaging algorithms as high-risk alongside existing MDR device classification, OEMs are increasingly embedding certified AI directly into CT, MRI, and X-ray systems rather than selling standalone software under a separate conformity assessment. This shifts European purchasing toward AI-Enabled Imaging Systems within the Hardware / Integrated Solutions category, consolidating regulatory cost into a single certified device rather than a stack of independently cleared components.

Segment Analysis

By Offering

• Software Tools / Platforms (largest) – Standalone algorithms and application suites that process, reconstruct, or interpret radiology, pathology, or other diagnostic images within existing clinical workflows

• Image Analysis & Diagnostic Software
• Workflow Orchestration & Triage Software
• Image Reconstruction Software
• PACS/RIS Integration Software
• Services – Consulting, implementation, integration, training, and maintenance support that helps healthcare providers deploy and operate AI imaging systems

• Deployment & Integration Services
• Training & Consulting Services
• Support & Maintenance Services
• Hardware / Integrated Solutions – Imaging equipment and workstations, such as scanners and viewing consoles, that embed or bundle AI processing capability directly into the device
• AI-Enabled Imaging Systems

• CT Systems
• MRI Systems
• X-ray Systems
• Ultrasound Systems

• Computing & Edge AI Hardware
• PACS Servers & Storage Infrastructure

Software Tools / Platforms leads the offering axis in 2025, ahead of Services and Hardware / Integrated Solutions. Hospitals can license diagnostic and triage algorithms onto existing PACS and RIS infrastructure without replacing imaging hardware, which keeps capital outlay low and lets a radiology department pilot a single indication before scaling. Software also follows the shortest regulatory path as a standalone medical device, unlike bundled hardware that requires full-system clearance. Hardware / Integrated Solutions is growing fastest, as original equipment manufacturers embed edge AI processing directly into new CT, MRI, X-ray and ultrasound consoles at the point of sale. Bundling compute into the scanner removes the integration burden that slows retrofit software deployments and ties service revenue to the console itself.

By Imaging Modality

• X-ray – A radiography technique that passes ionizing radiation through the body to produce two-dimensional images of bones and dense tissue for diagnostic screening
• Digital X-ray

• Direct Radiography (DR)
• Computed Radiography (CR)
• Analog X-ray
• Computed Tomography (CT) (largest) – An imaging technique that combines multiple X-ray projections taken from different angles to reconstruct cross-sectional and three-dimensional views of internal organs and structures

• High-Slice CT
• Mid-Slice CT
• Low-Slice CT
• Cone Beam CT (CBCT)
• Magnetic Resonance Imaging (MRI) – A scanning method that uses magnetic fields and radio waves to generate detailed images of soft tissue, organs, and the nervous system without ionizing radiation

• Low-Field MRI
• Mid-Field MRI
• High-Field MRI
• Very-High-Field MRI
• Ultrasound – An imaging modality that uses high-frequency sound waves to produce real-time images of internal organs, blood flow, and fetal development

• Cart-Based/Trolley Ultrasound
• Compact Ultrasound
• Handheld/Point-of-Care Ultrasound (POCUS)
• Positron Emission Tomography (PET) / SPECT – Nuclear imaging techniques that track injected radioactive tracers to visualize metabolic activity and physiological function within tissues and organs

• Standalone PET
• Standalone SPECT
• PET/CT
• PET/MRI
• SPECT/CT

Computed Tomography leads the imaging-modality axis in 2025, ahead of MRI, X-ray, ultrasound and PET/SPECT. CT’s volumetric, cross-sectional output suits deep-learning triage for stroke, pulmonary embolism and incidental lung nodules, and high emergency and oncology scan volumes give algorithm developers the largest labelled dataset to train against. A mature base of cleared CT algorithms also gives radiology groups more vendor choice than in other modalities. Ultrasound is growing fastest, pulled by handheld, point-of-care devices that pair AI-guided image acquisition with automated measurement. That combination lets non-specialist clinicians in primary care and emergency settings capture diagnostic-quality images without a sonographer, shifting volume away from centralized radiology scheduling toward bedside and community use.

Regional Analysis

North America held 40.0% of the AI-powered medical imaging market in 2025, the largest of the three regions tracked. The U.S. Food and Drug Administration has cleared a growing number of AI- and machine-learning-enabled imaging devices through its 510(k) pathway, and the Centers for Medicare & Medicaid Services reimburses select algorithms under dedicated Category III CPT codes, giving hospitals a billing path for AI-assisted CT and mammography reads. That combination of clearance activity and a funded reimbursement route keeps U.S. health systems the largest buyer of new imaging algorithms.

Europe accounted for 21.0% share in 2025, the smallest of the three regions. The EU Medical Device Regulation classifies most diagnostic imaging software as a medical device requiring notified-body certification, and the resulting recertification backlog for legacy PACS-integrated tools has slowed how quickly existing software can be relabelled for new AI functions. Vendors renewing a CE mark issued under the prior directive face a harder path than entrants filing fresh under MDR, a dynamic that favors newer cloud-native software suppliers over hardware incumbents carrying large installed bases across German, French and Italian hospital networks.

Asia Pacific held 29.0% share in 2025, second-largest of the three regions. China’s National Medical Products Administration has cleared an expanding list of domestic AI triage tools for stroke and lung-nodule screening through its innovative-device fast-track, while Japan’s PMDA has cleared imaging algorithms for national insurance listing. County-level hospitals brought into China’s tiered diagnosis and treatment system are a primary adoption channel, since AI triage lets facilities without a resident radiologist forward pre-screened studies to regional reading centers.

Competitive Landscape

The AI-powered medical imaging market is fragmented, spanning imaging-equipment OEMs, standalone software vendors, computing-hardware suppliers and specialist diagnostic-AI developers, with no single vendor holding a dominant share. Competition centers on regulatory clearance status and label breadth, since an algorithm’s approved indications determine which studies a hospital can bill for; on integration with existing PACS and RIS infrastructure, which lowers switching cost for radiology departments already running an OEM’s console; on installed imaging-equipment base, which lets scanner manufacturers pull their own AI licenses through at the point of sale rather than compete against portable third-party software; and on group-purchasing and integrated-delivery-network contracts, since a hospital system’s existing enterprise imaging agreement often determines which AI modules it can add without a separate procurement cycle. Established players include Siemens Healthineers, GE HealthCare, Koninklijke Philips, IBM Watson Health / Merative, NVIDIA, Canon Medical Systems, Fujifilm Holdings, Agfa-Gevaert, Nanox AI (formerly Zebra Medical Vision) and Lunit. The group spans imaging-hardware incumbents with decades of installed base alongside newer AI-native software vendors, since clinical validation and distribution reach matter as much as algorithm accuracy alone.

Strategic Outlook

The clearest whitespace lies in point-of-care ultrasound paired with AI-guided acquisition, which lets primary-care and emergency clinicians in regions with radiologist shortages capture diagnostic-quality studies without a sonographer. Realizing that opportunity depends on payers extending reimbursement coverage beyond hospital radiology departments to primary-care and community settings.

By 2035, offering mix is likely to tilt further toward hardware-embedded AI as OEMs bundle inference capability into new scanners at the point of sale, narrowing the standalone-software segment to indications not yet covered by a console vendor’s own algorithm.

AI-Powered Medical Imaging Market Report Scope